Patents Assigned to Proteovista LLC
  • Patent number: 10851423
    Abstract: Provided herein is technology relating to genetic determinants of disease and particularly, but not exclusively, to methods, compositions, and systems for identifying single nucleotide polymorphisms that are functionally associated with a disease.
    Type: Grant
    Filed: June 20, 2016
    Date of Patent: December 1, 2020
    Assignee: Proteovista LLC
    Inventors: Mary Szatkowski Ozers, Christopher L. Warren, Matthew J. Rodesch